Wells Fargo & Company Venus Concept Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.18 - $0.38 $0 - $1	3 Added 1.42%	215 $0
Q4 2022 Feb 13, 2023	BUY	$0.16 - $6.5 $1 - $78	12 Added 6.0%	212 $0
Q3 2022 Nov 14, 2022	SELL	$0.31 - $7.41 $1,186 - $28,350	-3,826 Reduced 95.03%	200 $0
Q2 2022 Aug 12, 2022	BUY	$0.45 - $1.57 $34 - $120	77 Added 1.95%	4,026 $2,000
Q1 2022 May 16, 2022	BUY	$1.29 - $1.85 $1 - $1	1 Added 0.03%	3,949 $6,000
Q3 2021 Nov 15, 2021	BUY	$1.79 - $3.27 $48 - $88	27 Added 0.69%	3,948 $10,000
Q2 2021 Aug 16, 2021	SELL	$1.72 - $3.19 $13,667 - $25,347	-7,946 Reduced 66.96%	3,921 $12,000
Q1 2021 May 13, 2021	SELL	$1.73 - $3.33 $3,584 - $6,899	-2,072 Reduced 14.86%	11,867 $28,000
Q4 2020 Feb 09, 2021	SELL	$1.67 - $2.63 $53,794 - $84,717	-32,212 Reduced 69.8%	13,939 $24,000
Q3 2020 Nov 05, 2020	SELL	$2.11 - $3.52 $23,450 - $39,121	-11,114 Reduced 19.41%	46,151 $107,000
Q2 2020 Aug 13, 2020	BUY	$2.52 - $4.76 $134,489 - $254,036	53,369 Added 1369.84%	57,265 $200,000
Q1 2020 May 14, 2020	BUY	$2.35 - $8.2 $9,155 - $31,947	3,896 New	3,896 $14,000

Ticker VERO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 65,459,600
Market Cap $39.3M
Description
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device us...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.